These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine. Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688 [TBL] [Abstract][Full Text] [Related]
6. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Su YC; Wan KL; Mohamed R; Nathan S Vaccine; 2010 Jul; 28(31):5005-11. PubMed ID: 20546831 [TBL] [Abstract][Full Text] [Related]
7. Identification of a LolC homologue in Burkholderia pseudomallei, a novel protective antigen for melioidosis. Harland DN; Chu K; Haque A; Nelson M; Walker NJ; Sarkar-Tyson M; Atkins TP; Moore B; Brown KA; Bancroft G; Titball RW; Atkins HS Infect Immun; 2007 Aug; 75(8):4173-80. PubMed ID: 17517877 [TBL] [Abstract][Full Text] [Related]
8. LVS Δ Tullius MV; Bowen RA; Back PS; Masleša-Galić S; Nava S; Horwitz MA mBio; 2024 Apr; 15(4):e0018624. PubMed ID: 38511933 [TBL] [Abstract][Full Text] [Related]
9. BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis. Tomás-Cortázar J; Bossi L; Quinn C; Reynolds CJ; Butler DK; Corcoran N; Murchú MÓ; McMahon E; Singh M; Rongkard P; Anguita J; Blanco A; Dunachie SJ; Altmann D; Boyton RJ; Arnold J; Giltaire S; McClean S Front Immunol; 2021; 12():767359. PubMed ID: 34966388 [TBL] [Abstract][Full Text] [Related]
10. A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Ulett GC; Labrooy JT; Currie BJ; Barnes JL; Ketheesan N Microbes Infect; 2005; 7(11-12):1263-75. PubMed ID: 16027024 [TBL] [Abstract][Full Text] [Related]
11. Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection. Healey GD; Elvin SJ; Morton M; Williamson ED Infect Immun; 2005 Sep; 73(9):5945-51. PubMed ID: 16113315 [TBL] [Abstract][Full Text] [Related]
12. Identification of an OmpW homologue in Burkholderia pseudomallei, a protective vaccine antigen against melioidosis. Casey WT; Spink N; Cia F; Collins C; Romano M; Berisio R; Bancroft GJ; McClean S Vaccine; 2016 May; 34(23):2616-21. PubMed ID: 27091689 [TBL] [Abstract][Full Text] [Related]
13. A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates. Baker SM; Davitt CJH; Motyka N; Kikendall NL; Russell-Lodrigue K; Roy CJ; Morici LA Vaccines (Basel); 2017 Dec; 5(4):. PubMed ID: 29232837 [No Abstract] [Full Text] [Related]
14. Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice. Chin CY; Tan SC; Nathan S Front Cell Infect Microbiol; 2012; 2():85. PubMed ID: 22919676 [TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders. Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962 [TBL] [Abstract][Full Text] [Related]
17. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei. Muruato LA; Tapia D; Hatcher CL; Kalita M; Brett PJ; Gregory AE; Samuel JE; Titball RW; Torres AG Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28903988 [No Abstract] [Full Text] [Related]